Biden to Lift COVID-19 Emergencies in May
TUESDAY, Jan. 31, 2023 (HealthDay News) -- The two COVID-19 emergency measures declared by the White House at the start of the pandemic will end in May.
President Joe Biden informed Congress of the plan on Monday, as part of a statement opposing House Republicans' plan to immediately end the protections.
"An abrupt end to the emergency declarations would create wide-ranging chaos and uncertainty throughout the health care system -- for states, for hospitals and doctors' offices, and, most importantly, for tens of millions of Americans," the Office of Management and Budget explained in the statement.
Instead, the Biden administration plans to extend both protections until May 11. After that, COVID-19 would be treated as an endemic threat managed by more typical public health authorities.
Some of the expected changes have already slowly rolled out, as most designated federal COVID-19 relief money has been spent and emergencies that allowed more Americans to have insurance have ended, the Associated Press reported. And lawmakers have not approved the Biden administration's request for billions to extend COVID-19 testing and vaccine coverage. Meanwhile, a spending package passed last year eliminated a rule that prevented states from discontinuing COVID-19-era Medicaid coverage. That coverage will end April 1.
Last but not least, the federal government will no longer have control over vaccines and treatments, which could ratchet up prices. Vaccine maker Pfizer has already said it will charge up to $130 per dose of its vaccine, which had until now been paid for by the federal government, the AP reported.
Related Posts
Study Looks at Access to Kidney Care for Undocumented Immigrants
MONDAY, April 24, 2023 (HealthDay News) -- Twenty states and the District of...
Comprenden cómo la COVID puede provocar la pérdida del olfato
JUEVES, 5 de mayo de 2022 (HealthDay News) -- Le ha sucedido a millones durante...
La exposición al aire contaminado de la madre en el embarazo podría dañar el desarrollo de un niño pequeño
JUEVES, 26 de enero de 2023 (HealthDay News) -- La exposición de una futura...
First Biosimilar Approved for Macular Degeneration, Other Eye Conditions
THURSDAY, Sept. 23, 2021 (HealthDay News) -- The first biosimilar to Lucentis...